Mayne Pharma Group Limited Investor Presentation Aaron Gray (CEO) Griffin Buchanan (CFO) 26 October 2026 Disclaimer The information provided is general in nature and is in summary form only. It is not complete and should be read in conjunction with the company’s audited Financial Statements and...
Investor presentation
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
In the deck
Earlier from Mayne Pharma
- Mayne Pharma reports unaudited Q1 FY27 results
- 2026 Notice of Annual General Meeting and shareholder pack
- MYX settles US patent litigation re Imvexxy with Teva USA
- Supreme Court Decision in Cosette Proceedings
- Trading Halt
Later from Mayne Pharma
All Mayne Pharma news releasesFollow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma